Moreover, high expression of SOX9 is significantly associated with reduced survival rate in adenocarcinoma of the lung (LUAD) (Fig. S6A), squamous cell carcinoma of the lung (LUSC) (Fig. S6B), or melanoma (Fig. S6C) patients. This evidence concerns the gene SOX9 and lung adenocarcinoma.